Uranium Energy Corp vs Health Care Select Sector SPDR Fund — how do they compare? Uranium Energy Corp trades at $9.2 (market cap $4.53B), while Health Care Select Sector SPDR Fund trades at $170.67 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 9.6× Uranium Energy Corp's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Uranium Energy Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Uranium Energy Corp for 37 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| UEC | XLV | |
|---|---|---|
Market Cap | $4.53B | $43.48B |
Volume | 10,888,578 | 11,121,431 |
Sector | Energy | — |
52-Week High | $20.14 | $175.68 |
52-Week Low | $9.04 | $141.95 |
Typical Hold Time | 37 Days | 100 Days |
Enterprise Value | $4.03B | — |
Signals from Pluang's Aura AI — not financial advice
UEC trades at $9.24, down 2.43% on the day, amid a bearish technical signal with moving averages indicating selling pressure. The company reported a net loss of -$87.66M in 2025, with revenue of $66.84M and a deeply negative net income margin of -368.62%. Recent news highlights operational expansion to two mines, but earnings misses in Q1 and Q2 2026 raise concerns about sustainability despite a Q4 beat.
Wall Street analysts remain bullish with an 87.5% buy rating and a $16.06 consensus price target, citing U.S. uranium demand growth. However, high cash burn, reliance on financing, and unproven production sustainability pose significant risks. The stock offers speculative upside if operational execution improves, but current fundamentals warrant caution.
XLV trades at $169.58 with a slight 0.46% daily gain amid bearish technical signals. The ETF faces selling pressure with moving averages indicating downward momentum while oscillators remain neutral. Recent news highlights XLV's competitive expense ratio of 0.08% and defensive healthcare sector positioning. Options activity shows increased put volume, suggesting some investor caution despite the fund's diversification across 61 healthcare stocks.
The healthcare ETF presents a cost-effective defensive play with potential upside if political volatility subsides post-elections. Key risks include sector-specific regulatory pressures and biotech trial failures impacting holdings. Current technical weakness near support at $166 requires monitoring for potential breakdown, though the fund's low fees and broad diversification provide stability during market uncertainty.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →